Developing quick tests for opioid and stimulant use disorders
Official title: Rapid Fingerstick Diagnostics for Opioid and Stimulant Use Disorders
Funded at Electronic Biosciences, INC. · NIH-11169097 · Data updated 2026-11-12
This study is working on a quick and easy test to help doctors find out if someone has problems with opioid or stimulant use, so they can get the right care faster, especially in places where help is hard to reach.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | April 1, 2025 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $386,452 |
| NIH project number | 1R43DA063260-01 |
| Project ID | NIH-11169097 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older who are experiencing or at risk for opioid and stimulant use disorders.
✕Less likely to help
Patients who are not experiencing substance use disorders or are under the age of 21 may not benefit from this research.
What this research studies
This research focuses on creating a rapid diagnostic tool for detecting opioid and stimulant use disorders, which are major public health issues in the U.S. The current methods for diagnosis are limited and often delayed, making it difficult for individuals to receive timely care. By developing a Point-of-Need diagnostic tool, the research aims to provide immediate results that can assess not only substance use but also related health indicators. This could significantly improve the ability to monitor and treat patients, especially in underserved areas.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses for individuals struggling with opioid and stimulant use disorders, ultimately saving lives.
How similar studies have gone: While there have been advancements in diagnostic tools for substance use, this specific approach is innovative and aims to address significant gaps in current methodologies.
Where this research is happening
-
Electronic Biosciences, INC.
San Diego, United States Active
Researchers
- Principal investigator: Ervin, Eric — Electronic Biosciences, INC.
- Study coordinator: Ervin, Eric
Related research
Other NIH-funded projects on the same topics.
-
Enabling protein sequencing with tiny nanopores
A new technology aims to read the exact amino acid sequence of a single protein molecule in real time using tiny protein-based pores.
-
Next-gen single-molecule protein sequencing for cancer profiling
A new single-molecule protein sequencing platform aims to directly read cancer-related proteins with ultra-high accuracy and through- put to reveal variants and modifications.
-
High-Fidelity DNA Sequencing of FMR1 CGG Repeats and Methylation in Fragile X
A new method will be developed to precisely measure CGG repeats and DNA methylation in the FMR1 gene to improve diagnosis and understanding of Fragile X–related autism.
-
At-home testing for prostate cancer using PSA levels
This study is working on a new, easy-to-use home testing device that helps men check their PSA levels for early signs of prostate cancer, making it simpler and more affordable for everyone to take care of their prostate health.
-
Developing a new method for sequencing proteins using enzymes
This study is working on a new way to read proteins one at a time, which could help doctors get better information about diseases and improve tests for patients, especially for those with rare or complicated proteins.
-
Developing advanced RNA sequencing technologies to understand gene expression and modifications.
This study is working on new ways to read RNA directly, which helps us see how genes work and how changes in RNA can affect our cells, making it easier to understand diseases and improve treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.